|
1
|
Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR. Nanovehicles for co-delivery of anticancer agents. Drug Discov Today 2020; 25:1416-1430. [DOI: 10.1016/j.drudis.2020.06.027] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Revised: 04/26/2020] [Accepted: 06/26/2020] [Indexed: 12/17/2022]
|
|
2
|
Ghiasi B, Mehdipour G, Safari N, Behboudi H, Hashemi M, Omidi M, Sefidbakht Y, Yadegari A, Hamblin MR. Theranostic applications of stimulus-responsive systems based on carbon dots. INT J POLYM MATER PO 2019; 70:117-130. [PMID: 33967355 PMCID: PMC8101985 DOI: 10.1080/00914037.2019.1695207] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2019] [Accepted: 11/09/2019] [Indexed: 12/29/2022]
Abstract
Over recent years, many different nanoparticle-based drug delivery systems (NDDSs) have been developed. Recently the development of stimulus-responsive NDDSs has come into sharper focus. Carbon dots (CDs) possess outstanding features such as useful optical properties, good biocompatibility, and the ability for easy surface modification. Appropriate surface modification can allow these NDDSs to respond to various chemical or physical stimuli that are characteristic of their target cells or tissue (frequently malignant cells or tumors). The present review covers recent developments of CDs in NDDSs with a particular focus on internal stimulus response capability that allows simultaneous imaging and therapeutic delivery (theranostics). Relevant stimuli associated with tumor cells and tumors include pH levels, redox potential, and different enzymatic activities can be used to activate the CDs at the desired sites.
Collapse
Affiliation(s)
- Behrad Ghiasi
- Protein Research Center, Shahid Beheshti University, Tehran, Iran
| | - Golnaz Mehdipour
- Protein Research Center, Shahid Beheshti University, Tehran, Iran
| | - Nooshin Safari
- Protein Research Center, Shahid Beheshti University, Tehran, Iran
| | | | - Mohadeseh Hashemi
- Protein Research Center, Shahid Beheshti University, Tehran, Iran
- Biomedical Engineering Department, The University of Texas at Austin, Austin, TX, USA
| | - Meisam Omidi
- School of Dentistry, Marquette University, Milwaukee, WI, USA
| | - Yahya Sefidbakht
- Protein Research Center, Shahid Beheshti University, Tehran, Iran
| | - Amir Yadegari
- School of Dentistry, Marquette University, Milwaukee, WI, USA
| | - Michael R. Hamblin
- Massachusetts General Hospital, Wellman Center for Photomedicine, Boston, MA, USA
- Department of Dermatology, Harvard Medical School, Boston, MA, USA
- Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa
| |
Collapse
|